Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Evolus, a performance beauty company, announced its participation in the 10th Annual SVB Leerink Global Healthcare Conference on February 24, 2021. The event will feature a fireside chat and one-on-one meetings from 1:00 PM to 1:30 PM ET. An audio webcast of the chat will be available on Evolus' investor relations website, with replays accessible for 90 days. Evolus is known for its innovative products, including Jeuveau®, a neurotoxin dedicated to aesthetics, approved by the FDA in 2019.

NEWPORT BEACH, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in the 10^th Annual SVB Leerink Global Healthcare Conference.

	Event:		10th Annual SVB Leerink Global Healthcare Conference
	Format:		Fireside Chat & 1x1 Meetings
	Date:		Wednesday, February 24, 2021
	Time:		1:00pm – 1:30pm ET
	Location:		Evolus Live Fireside Chat

An audio webcast of Evolus’ fireside chat will be available on the investor relations section of Evolus’ website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.

About Evolus, Inc.

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau^® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure^™ technology. Jeuveau^® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: www.evolus.com.

Jeuveau^® is a registered trademark of Evolus, Inc.

Hi-Pure^™ is a trademark of Daewoong Pharmaceutical Co, Ltd.

Evolus, Inc. Contacts:

Investor Contact:
Ashwin Agarwal, Evolus, Inc.
Vice President, Finance, Investor Relations & Treasury
Tel: +1-949-284-4559
Email: IR@Evolus.com

Media Contact:
Crystal Muilenburg, Evolus, Inc.
Vice President, Corporate Communications & Public Relations
Tel: +1-949-284-4506
Email: media@evolus.com

FAQ

What is the date of the 10th Annual SVB Leerink Global Healthcare Conference for Evolus?

The conference will take place on February 24, 2021.

What time is Evolus' fireside chat at the SVB Leerink Conference?

The fireside chat is scheduled from 1:00 PM to 1:30 PM ET.

Where can I listen to the Evolus fireside chat webcast?

The webcast will be available on Evolus' investor relations website.

How long will the webcast replay be available after the Evolus presentation?

The replay will be accessible for 90 days after the presentation.

What product did Evolus launch in 2019?

Evolus launched Jeuveau®, the first neurotoxin dedicated solely to aesthetics.